ABSTRACT
Background The efficacy of balloon pulmonary angioplasty (BPA) for chronic thromboembolic pulmonary disease (CTEPD) with or mild pulmonary hypertension (PH) or without PH remains unknown. Exercise pulmonary hypertension (Ex-PH) is associated with impaired exercise capacity and ventilatory efficiency, even under normalized pulmonary hemodynamics at rest. We hypothesized that patients with Ex-PH and/or hypoxemia would be candidates for BPA. We aimed to verify the prevalence and clinical profiles of Ex-PH and the effect of BPA on oxygenation and Ex-PH in patients with CTEPD with mean pulmonary arterial pressure (mPAP) < 25 mmHg.
Methods We retrospectively reviewed 29 patients with CTEPD and mPAP < 25 mmHg at rest, who had undergone a cardiopulmonary exercise test with right heart catheterization (median age, 65 years; 38% male). Patients were divided into two groups: Ex-PH, defined as a cardiac output slope (mPAP/CO slope) > 3.0, and non-Ex-PH.
Results Overall, six patients had mild PH (mPAP: 21–24 mmHg), and 16 and 13 were assigned to the Ex-PH and Non-Ex-PH groups, respectively. There were no significant differences in the clinical parameters, including hemodynamics at rest, blood gas analysis, and 6-minute walk distance, between the Ex-PH and Non-Ex-PH groups. Among the 16 patients with Ex-PH and/or long-term oxygen therapy (LTOT), BPA improved the World Health Organization-functional class (WHO-FC) and PaO2 in association with a decrease in the mPAP/CO slope. All nine patients discontinued LTOT after BPA. No significant complications were observed during each BPA session.
Conclusions Ex-PH was common among patients with CTEPD and mPAP < 25 mmHg. BPA can improve symptoms, oxygenation, and exercise hemodynamics in patients with CTEPD and Ex-PH and/or hypoxemia.
What is Known?
BPA has been recommended for patients with non-operable CTEPH.
Although there is still a small body of evidence, BPA for patients with CTEPD with mild PH (mPAP < 25 mmHg) or without PH can safely improve symptoms.
The prevalence of Ex-PH in CTEPD patients with or without PH is unknown.
What the Study Adds?
Approximately 50% of CTEPD patients with mild PH or without PH had Ex-PH.
What the Study Adds?In patients with CTEPD with mPAP < 25 mmHg, BPA improves exercising hemodynamics, such as the mPAP/CO slope, which could be a parameter to determine the indication for BPA.
The distribution of exercise pulmonary hypertension (Ex-PH) in patients with chronic thromboembolic pulmonary disease (CTEPD) with mild pulmonary hypertension (PH) or without PH, and efficacy of balloon pulmonary angioplasty (BPA) for CTEPD with Ex-PH and/or hypoxemia. Blue person symbols mean Ex-PH, and white person symbols mean non-Ex-PH.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No conflicts of interest or financial disclosures are associated with this study.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study complied with the Declaration of Helsinki and was approved by the Committee for Clinical Studies and Ethics of Kyorin University School of Medicine (Approval No.: H30-138).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Relationship with Industry Policy: No conflicts of interest or financial disclosures are associated with this study.
Data Availability
I state that all data referred to in the manuscript are available.
Non-standard Abbreviations and Acronyms
- 6-MWD
- six-minute walk distance
- BPA
- balloon pulmonary angioplasty
- CO
- cardiac output
- CPET-RHC
- cardiopulmonary exercise test with right heart catheterization
- CTEPH
- chronic thromboembolic pulmonary hypertension
- CTEPD
- chronic thromboembolic pulmonary disease
- Ex-PH
- exercise pulmonary hypertension
- LTOT
- long-term oxygen therapy
- mPAP
- mean pulmonary artery pressure
- OTLS
- organized thrombotic lesion score
- PAWP
- pulmonary artery wedge pressure
- PEA
- pulmonary endarterectomy
- PH
- pulmonary hypertension
- PPEI
- post-pulmonary embolism impairment
- PVR
- pulmonary vascular resistance
- RHC
- right heart catheterization
- VO2
- oxygen consumption
- VTE
- venous thromboembolism
- WHO-FC
- World Health Organization-functional class
